(Commission File Number) | (IRS Employer Identification No.) | |
(Address of principal executive offices) | (Zip Code) | ||
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Emerging growth company | ||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ | |
Item 2.02. | Results of Operations and Financial Condition. |
Item 8.01. | Other Events. |
Item 9.01. | Financial Statements and Exhibits. |
Exhibit Number | Description | |
99.1 | ||
104 | Inline XBRL for the cover page of this Current Report on Form 8-K | |
VERISIGN, INC. | ||||
Date: February 6, 2020 | By: | /s/ Thomas C. Indelicarto | ||
Thomas C. Indelicarto | ||||
Executive Vice President, General Counsel and Secretary | ||||
Exhibit No. | Description | |
Exhibit 99.1 | ||
Exhibit 104 | Inline XBRL for the cover page of this Current Report on Form 8-K | |

• | Verisign ended 2019 with cash, cash equivalents, and marketable securities of $1.22 billion, a decrease of $52 million from year-end 2018. |
• | Cash flow from operations was $194 million for the fourth quarter of 2019 and $754 million for the full year 2019 compared with $219 million for the same quarter in 2018 and $698 million for the full year 2018. |
• | Deferred revenues on Dec. 31, 2019, totaled $1.03 billion, an increase of $16 million from year-end 2018. |
• | During the fourth quarter, Verisign repurchased 1.0 million shares of its common stock for $195 million. During the full year 2019, Verisign repurchased 3.9 million shares of its common stock for $738 million. |
• | Effective Feb. 6, 2020 the Board of Directors approved an additional authorization for share repurchases of approximately $743 million of common stock, which brings the total amount to $1.0 billion authorized and available under Verisign’s share repurchase program, which has no expiration. |
• | Verisign ended the fourth quarter with 158.8 million .com and .net domain name registrations in the domain name base, a 3.9 percent increase from the end of the fourth quarter of 2018, and a net increase of 1.46 million registrations during the fourth quarter of 2019. |
• | In the fourth quarter, Verisign processed 10.3 million new domain name registrations for .com and .net, as compared to 9.5 million for the same quarter in 2018. |
• | The final .com and .net renewal rate for the third quarter of 2019 was 73.7 percent compared with 74.8 percent for the same quarter in 2018. Renewal rates are not fully measurable until 45 days after the end of the quarter. |
December 31, 2019 | December 31, 2018 | ||||||
ASSETS | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 508,196 | $ | 357,415 | |||
Marketable securities | 709,863 | 912,254 | |||||
Other current assets | 60,530 | 47,365 | |||||
Total current assets | 1,278,589 | 1,317,034 | |||||
Property and equipment, net | 250,283 | 253,905 | |||||
Goodwill | 52,527 | 52,527 | |||||
Deferred tax assets | 87,798 | 104,992 | |||||
Deposits to acquire intangible assets | 145,000 | 145,000 | |||||
Other long-term assets | 39,812 | 41,046 | |||||
Total long-term assets | 575,420 | 597,470 | |||||
Total assets | $ | 1,854,009 | $ | 1,914,504 | |||
LIABILITIES AND STOCKHOLDERS’ DEFICIT | |||||||
Current liabilities: | |||||||
Accounts payable and accrued liabilities | $ | 209,988 | $ | 215,208 | |||
Deferred revenues | 755,178 | 732,382 | |||||
Total current liabilities | 965,166 | 947,590 | |||||
Long-term deferred revenues | 278,702 | 285,720 | |||||
Senior notes | 1,787,565 | 1,785,047 | |||||
Long-term tax and other liabilities | 312,676 | 281,621 | |||||
Total long-term liabilities | 2,378,943 | 2,352,388 | |||||
Total liabilities | 3,344,109 | 3,299,978 | |||||
Commitments and contingencies | |||||||
Stockholders’ deficit: | |||||||
Preferred stock—par value $.001 per share; Authorized shares: 5,000; Issued and outstanding shares: none | — | — | |||||
Common stock—par value $.001 per share; Authorized shares: 1,000,000; Issued shares: 353,157 at December 31, 2019 and 352,325 at December 31, 2018; Outstanding shares: 116,715 at December 31, 2019 and 120,037 at December 31, 2018 | 353 | 352 | |||||
Additional paid-in capital | 14,989,658 | 15,706,774 | |||||
Accumulated deficit | (16,477,490 | ) | (17,089,789 | ) | |||
Accumulated other comprehensive loss | (2,621 | ) | (2,811 | ) | |||
Total stockholders’ deficit | (1,490,100 | ) | (1,385,474 | ) | |||
Total liabilities and stockholders’ deficit | $ | 1,854,009 | $ | 1,914,504 | |||
Three Months Ended December 31, | Year Ended December 31, | ||||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||||
Revenues | $ | 310,543 | $ | 307,452 | $ | 1,231,661 | $ | 1,214,969 | |||||||
Costs and expenses: | |||||||||||||||
Cost of revenues | 46,454 | 48,368 | 180,467 | 192,134 | |||||||||||
Sales and marketing | 13,862 | 17,179 | 46,637 | 64,891 | |||||||||||
Research and development | 15,101 | 15,042 | 60,805 | 57,884 | |||||||||||
General and administrative | 36,560 | 32,897 | 137,625 | 132,668 | |||||||||||
Total costs and expenses | 111,977 | 113,486 | 425,534 | 447,577 | |||||||||||
Operating income | 198,566 | 193,966 | 806,127 | 767,392 | |||||||||||
Interest expense | (22,712 | ) | (22,634 | ) | (90,611 | ) | (114,845 | ) | |||||||
Non-operating income, net | 9,123 | 62,570 | 43,260 | 76,969 | |||||||||||
Income before income taxes | 184,977 | 233,902 | 758,776 | 729,516 | |||||||||||
Income tax expense | (36,652 | ) | (51,707 | ) | (146,477 | ) | (147,027 | ) | |||||||
Net income | 148,325 | 182,195 | 612,299 | 582,489 | |||||||||||
Other comprehensive (loss) income | (202 | ) | 192 | 190 | 130 | ||||||||||
Comprehensive income | $ | 148,123 | $ | 182,387 | $ | 612,489 | $ | 582,619 | |||||||
Earnings per share: | |||||||||||||||
Basic | $ | 1.27 | $ | 1.51 | $ | 5.17 | $ | 5.13 | |||||||
Diluted | $ | 1.26 | $ | 1.50 | $ | 5.15 | $ | 4.75 | |||||||
Shares used to compute earnings per share | |||||||||||||||
Basic | 117,169 | 120,591 | 118,513 | 113,452 | |||||||||||
Diluted | 117,658 | 121,329 | 118,968 | 122,661 | |||||||||||
Year Ended December 31, | |||||||
2019 | 2018 | ||||||
Cash flows from operating activities: | |||||||
Net income | $ | 612,299 | $ | 582,489 | |||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
Depreciation of property and equipment | 46,330 | 48,367 | |||||
Stock-based compensation | 50,626 | 52,504 | |||||
Amortization of discount on investments in debt securities | (14,777 | ) | (18,259 | ) | |||
Gain on sale of business | (817 | ) | (54,840 | ) | |||
Other, net | 3,668 | 14,646 | |||||
Changes in operating assets and liabilities: | |||||||
Other assets | (3,279 | ) | 1,041 | ||||
Accounts payable and accrued liabilities | (24 | ) | (2,130 | ) | |||
Deferred revenues | 16,191 | 19,825 | |||||
Net deferred income taxes and other long-term tax liabilities | 43,675 | 54,124 | |||||
Net cash provided by operating activities | 753,892 | 697,767 | |||||
Cash flows from investing activities: | |||||||
Proceeds from maturities and sales of marketable securities | 2,247,904 | 4,031,809 | |||||
Purchases of marketable securities | (2,030,521 | ) | (2,976,752 | ) | |||
Purchases of property and equipment | (40,316 | ) | (37,007 | ) | |||
(Payments) Proceeds from sale of business | (9,872 | ) | 52,240 | ||||
Other investing activities | — | (160 | ) | ||||
Net cash provided by investing activities | 167,195 | 1,070,130 | |||||
Cash flows from financing activities: | |||||||
Repurchases of common stock | (782,583 | ) | (638,152 | ) | |||
Proceeds from employee stock purchase plan | 13,152 | 12,836 | |||||
Repayment of principal on subordinated convertible debentures | — | (1,250,009 | ) | ||||
Other financing activities | (872 | ) | — | ||||
Net cash used in financing activities | (770,303 | ) | (1,875,325 | ) | |||
Effect of exchange rate changes on cash, cash equivalents and restricted cash | 64 | (958 | ) | ||||
Net increase (decrease) in cash, cash equivalents and restricted cash | 150,848 | (108,386 | ) | ||||
Cash, cash equivalents, and restricted cash at beginning of period | 366,753 | 475,139 | |||||
Cash, cash equivalents, and restricted cash at end of period | $ | 517,601 | $ | 366,753 | |||
Supplemental cash flow disclosures: | |||||||
Cash paid for interest | $ | 87,683 | $ | 117,956 | |||
Cash paid for income taxes, net of refunds received | $ | 89,974 | $ | 84,906 | |||
Three Months Ended December 31, | |||||||||||||||
2019 | 2018 | ||||||||||||||
Operating Income | Net Income | Operating Income | Net Income | ||||||||||||
GAAP as reported | $ | 198,566 | $ | 148,325 | $ | 193,966 | $ | 182,195 | |||||||
Adjustments: | |||||||||||||||
Stock-based compensation | 12,389 | 12,389 | 11,098 | 11,098 | |||||||||||
Tax adjustment | (6,768 | ) | (2,193 | ) | |||||||||||
Non-GAAP | $ | 210,955 | $ | 153,946 | $ | 205,064 | $ | 191,100 | |||||||
Revenues | $ | 310,543 | $ | 307,452 | |||||||||||
Non-GAAP operating margin | 67.9 | % | 66.7 | % | |||||||||||
Diluted shares | 117,658 | 121,329 | |||||||||||||
Diluted EPS, non-GAAP | $ | 1.31 | $ | 1.58 | |||||||||||
Year Ended December 31, | |||||||||||||||
2019 | 2018 | ||||||||||||||
Operating Income | Net Income | Operating Income | Net Income | ||||||||||||
GAAP as reported | $ | 806,127 | $ | 612,299 | $ | 767,392 | $ | 582,489 | |||||||
Adjustments: | |||||||||||||||
Stock-based compensation | 50,626 | 50,626 | 52,504 | 52,504 | |||||||||||
Non-cash interest expense | — | 5,719 | |||||||||||||
Loss on debt extinguishment | — | 6,554 | |||||||||||||
Tax adjustment | (31,591 | ) | (27,717 | ) | |||||||||||
Non-GAAP | $ | 856,753 | $ | 631,334 | $ | 819,896 | $ | 619,549 | |||||||
Revenues | $ | 1,231,661 | $ | 1,214,969 | |||||||||||
Non-GAAP operating margin | 69.6 | % | 67.5 | % | |||||||||||
Diluted shares | 118,968 | 122,661 | |||||||||||||
Diluted EPS, non-GAAP | $ | 5.31 | $ | 5.05 | |||||||||||
Year Ended December 31, 2019 | |||
Net Income | $ | 612,299 | |
Interest expense | 90,611 | ||
Income tax expense | 146,477 | ||
Depreciation and amortization | 46,330 | ||
Stock-based compensation | 50,626 | ||
Unrealized gain on hedging agreements | (235 | ) | |
Gain on sale of business | (817 | ) | |
Non-GAAP Adjusted EBITDA | $ | 945,291 | |
Three Months Ended December 31, | Year Ended December 31, | ||||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||||
Cost of revenues | $ | 1,675 | $ | 1,652 | $ | 6,739 | $ | 6,835 | |||||||
Sales and marketing | 889 | 579 | 3,755 | 4,972 | |||||||||||
Research and development | 1,626 | 1,696 | 6,370 | 6,728 | |||||||||||
General and administrative | 8,199 | 7,171 | 33,762 | 33,969 | |||||||||||
Total stock-based compensation expense | $ | 12,389 | $ | 11,098 | $ | 50,626 | $ | 52,504 | |||||||